More and more employers are demanding commitment to weight reduction

Speculation in regards to the IPO in 2025

By Arthur Allen, KFF Health News

Most employers have little idea what the pharmacy profit managers they hire do with the cash they trade for the medications their employees use, in accordance with a brand new KFF survey.

In probably the most recent KFF Employer Health Benefits Survey, company representatives were asked how much of the rebates that pharmacy profit managers (PBMs) receive from drug manufacturers is paid back to them. In recent years, the pharmaceutical industry has tried to deflect criticism of high drug prices by claiming that much of that revenue is diverted from PBMs, corporations that manage drug advantages for patients on behalf of employers and health insurers.

PBM executives say they save corporations and patients billions of dollars annually by getting rebates from drugmakers that they pass on to employers. Drugmakers, meanwhile, say they’re raising their list prices so high that they will afford the discounts that PBMs demand in exchange for including the drugs in formularies they make available to patients.

Leaders of the three largest PBMs – CVS Caremark, Optum RX and Express Scripts – all testified before Congress in July that 95 to 98% of the rebates they receive from drug manufacturers go to employers.

For the KFF survey of two,142 randomly chosen corporations, officials from corporations with 500 or more employees were asked how much of the rebates negotiated by PBMs return to the corporate as savings. About 19% said they received probably the most discounts, 27% said some and 16% said little. 37 percent of those surveyed didn’t know.

While a bigger percentage of officials at the most important corporations said they received most or among the rebates, the responses — and their contrast with statements from PBM executives — reflect employers' confusion or ignorance about what their managers are on the lookout for Drug advantages do, says survey leader Gary Claxton, senior vice chairman at KFF, a nonprofit health information organization that features KFF Health News.

“I don't think they can ever know how the money is moving because there are so many layers, between the wholesalers, the pharmacies and the manufacturers,” he said.

Critics say large PBMs – that are parts of conglomerates that include pharmacies, providers and insurers – can hide the scale of their rebates by negotiating through corporate-controlled rebate aggregators or group buyers, most of that are based abroad in tax havens and these siphon off a percentage of the cash before it hits the PBMs' books.

PBMs also earn money by encouraging or requiring patients to go to affiliated specialty pharmacies, by saving on payments to other pharmacies, and by collecting additional money from pharmaceutical corporations through the federal drug pricing program 340B, which goals to cut back drug costs for low-income earners patients, said Antonio Ciaccia, CEO of 46brooklyn Research.

The KFF survey shows how little employers understand PBMs and their pricing policies. “Employers are generally frustrated by the lack of transparency in all pricing,” Claxton said. “You can’t really know what’s true.”

Billionaire Mark Cuban founded an organization to undercut PBMs by selling drugs with transparent pricing policies. He tells Fortune 500 executives he meets: “You get scammed, you lose money because understanding how your PBM and health insurance contracts work is not your core competency,” Cuban said in an interview with KFF Health on Tuesday News.

Ciaccia, who has conducted PBM research for several states, said employers are unable to know PBMs' behavior and are sometimes surprised at how unregulated the PBM business is.

“The assumption is that employers want to pay less and pay more attention,” he said. “But what I learned is that they are often under-equipped, under-resourced, and often don’t understand how severe the lack of oversight and accountability is.”

Employers may assume that PBMs will act of their best interests, but they should not legally required to accomplish that.

Prices can apply anywhere on the map, even those charged by the identical PBM, Ciaccia said. In a recent Medicaid study he conducted, a PBM charged employers between $2,000 and $8,000 for a month of imatinib, a cancer drug available as a generic for just $30.

PBM contracts often guarantee discounts of certain percentage points for generic and brand-name drugs. But the contracts then contain five pages of exclusions, and “no employer will know what they mean,” Ciaccia said. “This person does not have enough information to form an informed opinion.”

The KFF survey found that corporations' annual premiums for coverage for individual employees rose from a mean of $7,739 in 2021 to $8,951 this yr, and for families from $22,221 to $25,572. Among employers' biggest concerns was find out how to cover increasingly popular weight-loss medications, which cost $2,000 or more monthly.

Only 18% of respondents said their corporations cover weight reduction medications like Wegovy. The largest group of employers offering such coverage – 28% – were those with 5,000 or more employees.

©2024 KFF Health News. Distributed by Tribune Content Agency, LLC.

By Tom Murphy, Associated Press

An increase in healthcare spending is on the horizon in the brand new 12 months, and the Business Group on Health helps employers understand it.

The nonprofit present in a recent survey that enormous employers expect the price of treating patients to rise nearly 8% next 12 months before making coverage changes to handle that. This is the very best growth rate in a decade.

Ellen Kelsay, CEO of the Business Group on Health, expects employers to be more selective in regards to the care people receive. They may even try to regulate the use of costly treatments for obesity and diabetes.

Kelsay's nonprofit organization advises employers on health care costs and policy issues. The CEO recently spoke to The Associated Press.

Q: Large employers expect healthcare costs to rise next 12 months. How will they take care of this?

A: They will deal with the standard of services they supply to their employees. You may hear about high performance networks or centers of excellence. These are efforts through which employers hunt down the very best quality providers and try and encourage their workforce to hunt services through these providers.

Q: Does this mean employees can have fewer options for care?

A: You will see more curated, designed networks with perhaps fewer providers. But they will likely be of upper quality.

Q: Your annual survey also found that improving access to mental health care is an enormous priority for big employers. Why does she care?

A: It's fundamental. A one that is battling an issue at work or outside of labor is not going to be as engaged, as productive, or as healthy.

Q: How will employers handle expensive and popular weight reduction medications like Wegovy?

A: Most view it as a tool of their overall weight management strategy…not the one tool. (They) will really deal with who’s the suitable population to receive these medications. Does a provider recommend this? Does the person have certain comorbidities? Does the person have a (body mass index) that reaches a certain threshold? And does the person then also take part in a life-style and behavior change program to make sure long-term success?

Q: Eight of your 10 business leaders are women. How does this shape the vision or direction?

A: I feel we work thoroughly together. We deal with incorporating belonging, constructive discourse and promoting diverse perspectives.

Q: You have been covering worker advantages trends for greater than 20 years. What surprised you probably the most?

A: It's this sobering ongoing increase in basic health care costs. We've been talking about this for a long time. There is actually a number of good being done, but it surely is just not enough.

Originally published: October 16, 2024 at 11:41 am

Latest technology in healthcare

Most American employees are hired “at will.”“: Employers owe their employees nothing in the connection aside from wages earned, and employees are free to terminate at their very own discretion. The general rule is that either party may terminate the agreement at any time for good reason, bad reason, or no reason in any respect.

In keeping with this non-binding spirit, employees are free to maneuver on as they please – unless they occur to be a part of it Tens of thousands and thousands of employees tied down through a contract that expressly prohibits being hired by a competitor. This Non-compete clauses This may make sense for CEOs and other top executives who’ve trade secrets, but in practice they’ll seem nonsensical low-wage employees similar to B. Draftsman in the development industry.

President Joe Biden expressed concern on the repressive nature of non-compete clauses in July 2021.

And the Federal Trade Commission – a federal agency liable for actions that reduce competition within the economy – has now decided to ban them. On April 23, 2024In a 3-2 voteThe majority agreed to limit non-compete clauses.

Existing non-compete clauses for senior executives remain in place, but all others remain in effect with a couple of exceptions now not be enforceable.

The regulation is as a consequence of come into force at the top of August. However, legal motion could delay or block these changes. The US Chamber of Commerce and other Business groups sued the federal government to stop shortly after the FTC vote.

As a Scientist for labor law and policyI even have many concerns about non-compete agreements – similar to the indisputable fact that they have an inclination to exacerbate power imbalances in relationships between employees and managers, depresses wages and hinders labor market mobility.

Labor rights and the law

Courts began doing this Anchoring the arbitrary doctrine within the nineteenth centuryExceptions only apply to employees with fixed-term contracts.

With the adoption of the National Labor Relations Act In 1935, all private sector employees and unions gained the facility to bargain collectively with employers. Subsequent employment contracts, similar to the one negotiated by the Steel Workers Organizing Committee The agreement with Carnegie-Illinois Steel in 1937 required employers to indicate “just cause” before firing an individual covered by the contract.

The Civil Rights Acts of 1964 and 1991 additional employment protections that prohibit discrimination based on race, gender, religion, and national origin. And that Americans with Disabilities Actwhich Congress passed in 1990 ensured that individuals with disabilities had access to jobs with or without reasonable accommodations.

These laws and other measures, including modern exceptions to the discretionary rule, provide employees with some job security.

But despite some restrictions by individual state governmentsPreviously, there was no federal protection against non-compete agreements.

Non-compete agreements and low-wage employees

FTC Chairman Lina Khan estimated that just about one in five employees are employedsome 30 million Americansare on this boat.

Non-compete clauses are more common amongst higher-paid Americans, but greater than One in 10 employees earns $20 or less According to a 2021 study by the Federal Reserve Bank of Minneapolis, non-compete agreements apply for each hour.

Wages for US employees will rise by $400 billion to $488 billion over the following decade Once there are fewer non-compete agreements, the FTC estimates.

With the announcement of the ban he said The FTC advised employers who may fear losing high-performing employees in consequence of the brand new rules.

“Instead of using non-compete agreements to retain workers, employers who want to retain employees can compete for the employee’s performance on the basis of their performance by improving wages and working conditions.”

In other words, when employers pay their employees higher, their employees are happier and fewer more likely to quit.

Portions of this text were contained in an article originally published on July 13, 2021.